| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |